Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-26
2000-08-22
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01N 4338
Patent
active
06107327&
ABSTRACT:
A method for treating HIV infection is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N, N'-1,1'-((2"-ethoxy)-3'"(O)-4'"-(N,N-dimethylamino)-butane)-bis-(3,3'-indo lyl)]-1(H)-pyrrole-2,5-dione or its acid salt.
REFERENCES:
patent: 5057614 (1991-10-01), Davis et al.
patent: 5481003 (1996-01-01), Gillig et al.
patent: 5491242 (1996-02-01), Gillig et al.
patent: 5545636 (1996-08-01), Heath et al.
patent: 5552396 (1996-09-01), Heath et al.
patent: 5621098 (1997-04-01), Heath et al.
Nobecli. 114 CA: 239669j, 1990.
Takahashi et al 112 CA: 69462a, 1989.
Ghosh, et al., Nature, 344:678-682 (1990).
Jakobovits, et al., J. EMBO, 9:1165-1170 (1990).
Kinter et al., J. Virology 64: 4306-4312, 1990.
Laurence, et al., Biochem. Biophys. Res. Comm., 166:349-357 (1990).
Matthes et al., Antiviral Res., 13:273-286 (1990).
Mosier et al., Immunology Today 15: 332-339, 1994.
Nabel, et al., Nature, 326:711-713 (1987).
Sodroski et al., Science 227: 171-173, 1985.
Jeffrey Lawrence et al. "Phorbol Ester-Mediated Induction of HIV-1 from a Chronically Infected Promonocyte Clone: Blockade by Protein Kinase Inhibitors and Relationship to Tat-Directed Trans-Activation" Biochemical and Biophysical Research Communications, vol. 166, No. 1, Jan. 15, 1990, pp. 349-357.
Wilkinson et al., "Isoenzyme Specificity of Bisindolylmaleimides Selective Inhibitors of Protein Kinase C," Biochem. J., vol. 294, No. 2, 335-337, 1993.
Fields, et al., "Human Immunodeficiency Virus Reduces Phosphorylation of its Cell Surface Receptor," Letters to Nature, vol. 333, No. 6170, 278-280, 1988.
Ito, et al., "Mechanism of Inhibitory Effect of Glycyrrhizin on Replication of Human Immunodeficiency Virus (HIV)," Antiviral Research, vol. 10, No. 6, 289-298, 1988.
Jirousek Michael R.
Stramm Lawrence E.
Ways Douglas Kirk
Darkes Paul R.
Eli Lilly and Company
Travers Russell
LandOfFree
Therapeutic treatment for HIV infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic treatment for HIV infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment for HIV infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581554